Role
10%+ Owner
Signature
/s/ Crystal Landsem, Attorney-in-Fact
Issuer symbol
LVLU
Transactions as of
10 Nov 2021
Net transactions value
$0
Form type
3
Filing time
10 Nov 2021, 20:37:42 UTC
Next filing
17 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LVLU Series B Preferred Stock 207,232 10 Nov 2021 Directly held by Institutional Venture Partners XV, L.P. F1
holding LVLU Series B Preferred Stock 1,102 10 Nov 2021 Directly held by Institutional Venture Partners XV Executive Fund, L.P. F2
holding LVLU Series B Preferred Stock 208,383 10 Nov 2021 Directly held by Institutional Venture Partners XVI, L.P. F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LVLU Series A Preferred Stock 10 Nov 2021 Common Stock 3,730,160 Directly held by Institutional Venture Partners XV, L.P.( F1, F4
holding LVLU Series A Preferred Stock 10 Nov 2021 Common Stock 19,843 Directly held by Institutional Venture Partners XV Executive Fund, L.P. F2, F4
holding LVLU Series A Preferred Stock 10 Nov 2021 Common Stock 3,749,998 Directly held by Institutional Venture Partners XVI, L.P. F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Institutional Venture Management XV, LLC ("IVM XV") is the general partner of Institutional Venture Partners XV, L.P. ("IVP XV"). Todd C. Chaffee, Somesh Dash, Norman A. Fogelsong, Stephen J. Harrick, Jules A. Maltz, J. Sanford Miller and Dennis B. Phelps (collectively, the "Managing Directors") and Eric Liaw are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV. Each of IVM XV and the Managing Directors disclaims beneficial ownership of these securities, except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Liaw is a director of the Issuer and files separate Section 16 reports.
F2 IVM XV is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV-EF"). The Managing Directors and Eric Liaw are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV-EF. Each of IVM XV and the Managing Directors disclaims beneficial ownership of these securities, except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Liaw is a director of the Issuer and files separate Section 16 reports.
F3 Institutional Venture Management XVI, LLC ("IVM XVI") is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). The Managing Directors and Eric Liaw are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVP XVI. Each of IVM XVI and the Managing Directors disclaims beneficial ownership of these securities, except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Liaw is a director of the Issuer and files separate Section 16 reports.
F4 Each share of Series A Preferred Stock will automatically convert into shares of Common Stock on a 1:4.79289 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date.

Remarks:

2 of 2: The number of joint filers exceeds the EDGAR maximum of 10 joint filers per Form. This Form 3 is being filed in conjunction with a Form 3 being filed by Institutional Venture Management XV, LLC. Exhibit 24 - Power of Attorney.